Clinical Trial Update: Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma [EARLY_Phase 1]

View source ↗

Summary

This early-phase trial is evaluating memory-like natural killer (NK) cell therapy in patients with renal cell carcinoma and urothelial carcinoma, and is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chromophobe Renal Cell Carcinoma
• Renal Cell Carcinoma
• Translocation Renal Cell Carcinoma
• Urothelial Carcinoma

Drugs mentioned

• Memory-like natural killer (NK) cell therapy

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Renal Carcinoma, Renal Cell Carcinoma | EARLY_Phase 1 | Status: RECRUITING